Bcl-2 antagonist killer 1 (BAK1) polymorphisms influence the risk of developing autoimmune rheumatic disease in women

Authors :: Delgado-Vega, A.M.
Castiblanco, J.
Gomez, L.M.
Diaz-Gallo, L.-M.
Rojas-Villarraga, A.
Anaya, J.-M.
Source :: Annals of the Rheumatic Diseases. Feb, 2010, Vol. 69 Issue 2, p462, 4 p.
Publication Year :: 2010

Subjects :: Rheumatic diseases -- Genetic aspects
Rheumatic diseases -- Risk factors
Rheumatic diseases -- Research
Rheumatic diseases -- Demographic aspects
Genetic polymorphisms -- Research
Apoptosis -- Genetic aspects
Apoptosis -- Research
Women -- Health aspects
Women -- Research
Health

Tools